• The Barrow Neuroplex
  • Find a Doctor
  • International Patients
  • Contact Us
  • Patients & Families
  • Education
  • Research
  • Departments & People
  • News & Stories
  • Transfer a Patient
  • 261AS101

    Enrollment Information

    Call (602) 406-406-6606 or E-Mail [email protected]

    The purpose of this study is to evaluate the safety and tolerability of BIIB100 in adults with ALS. There are three in-person visits, including an overnight inpatient hospital stay where the study medication is administered orally at one time point, and one final phone visit required for this study.

    The trial may last about 7 weeks from the time of screening through the observation period.

    Principal Investigators: Shafeeq Ladha, MD

    About Barrow Neurological Institute
    Since our doors opened as a regional specialty center in 1962, we have grown into one of the premier destinations in the world for neurology and neurosurgery. Our experienced, highly skilled, and comprehensive team of neurological specialists can provide you with a complete spectrum of care–from diagnosis through outpatient neurorehabilitation–under one roof. Barrow Neurological Institute: Discover. Educate. Heal.